Patents by Inventor Haruyoshi Ueo

Haruyoshi Ueo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preventives or remedies for heart failure
    Patent number: 6878689
    Abstract: Preparations for preventing or treating acute heart failure, chronic heart failure at a phase of acute exacerbation or heart failure at a phase of transition to chronic heart failure, which contain D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide and/or salts thereof as an active ingredient.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: April 12, 2005
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Takahiko Murata, Haruyoshi Ueo, Tadashi Ohyama
  • Neuroprotective drug
    Patent number: 6849597
    Abstract: An agent for prevention or treatment of diseases involving degeneration or death of nerve cells, characterized by containing a growth hormone secretion promoting substance as an active ingredient, is provided.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: February 1, 2005
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Takahiko Murata, Tadashi Ohyama, Masahiro Amakawa, Keiko Fujita, Haruyoshi Ueo
  • Preventives or remedies for heart failure
    Publication number: 20040014671
    Abstract: Preparations for preventing or treating acute heart failure, chronic heart failure at a phase of acute exacerbation or heart failure at a phase of transition to chronic heart failure, which contain D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide and/or salts thereof as an active ingredient.
    Type: Application
    Filed: December 23, 2002
    Publication date: January 22, 2004
    Inventors: Takahiko Murata, Haruyoshi Ueo, Tadashi Ohyama
  • Nerve protective drugs
    Publication number: 20030100494
    Abstract: An agent for prevention or treatment of diseases involving degeneration or death of nerve cells, characterized by containing a growth hormone secretion promoting substance as an active ingredient, is provided.
    Type: Application
    Filed: June 27, 2002
    Publication date: May 29, 2003
    Inventors: Takahiko Murata, Tadashi Ohyama, Masahiro Amakawa, Keiko Fujita, Haruyoshi Ueo